Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Mar

@article{Rizzo2006RecommendedSA,
  title={Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Mar},
  author={J D Rizzo and J R Wingard and Andr{\'e} Tichelli and S J Lee and M T Van Lint and L J Burns and S M Davies and James L. M. Ferrara and G Soci{\'e}},
  journal={Bone Marrow Transplantation},
  year={2006},
  volume={37},
  pages={249-261}
}
  • J D Rizzo, J R Wingard, +6 authors G Socié
  • Published 2006 in Bone Marrow Transplantation
  • DOI:10.1038/sj.bmt.1705243
More than 40 000 hematopoietic cell transplants (HCTs) are performed worldwide each year. With improvements in transplant technology, larger numbers of transplant recipients survive free of the disease for which they were transplanted. However, there are late complications that can cause substantial morbidity. Many survivors are no longer under the care of transplant centers and many community health-care providers may be unfamiliar with health matters relevant to HCT. The Center for… CONTINUE READING